Glucuronidation of Drugs: A Re-Evaluation of the Pharmacological Significance of the Conjugates and Modulating Factors

Clinical Pharmacokinetics

Volumn 23, Issue 4, 1992, Pages 292-310

  Kroemer, Heyo K ^a   Klotz, Ulrich ^a  

^a DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARPROFEN; CLOFIBRIC ACID; CODEINE; DIGITOXIN; DIGOXIN; DRUG METABOLITE; GLUCURONIDE; IMIPRAMINE; LORAZEPAM; MORPHINE; MORPHINE 3 GLUCURONIDE; MORPHINE 6 GLUCURONIDE; NALOXONE; NITRAZEPAM; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; OXAZEPAM; PARACETAMOL; PHENAZONE; PROBENECID; RIFAMPICIN; RITODRINE; SALICYLIC ACID; VALPROIC ACID; ZIDOVUDINE; ZOMEPIRAC;

ANALGESIC ACTIVITY; BLOOD BRAIN BARRIER; DRUG BINDING; DRUG EFFECT; DRUG MECHANISM; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG TOXICITY; GLUCURONIDATION; IMMUNE RESPONSE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

AGE FACTORS; GLUCURONATES; GLUCURONOSYLTRANSFERASE; HUMAN; PHARMACOKINETICS;

EID: 0026737244     PISSN: 03125963     EISSN: 11791926     Source Type: Journal    
DOI: 10.2165/00003088-199223040-00005     Document Type: Review

References (176)

1. Drug disposition in obese humans: an update
2. Probenecid impairment of acetaminophen and lorazepam clearance: direct inhibition of ether glucuronide formation
3. Enhanced glucuronide conjugation of drugs in obesity studies of lorazepam, oxazepam and acetaminophen
4. Increased metabolic clearance of acetaminophen with oral contraceptive use
5. Glucuronide conjugation in the lung
6. Antitumor activity of methyl (5-fluoro-1H-2-oxo-4-pyrimidinyl β-D-glucopyranosid)uronate against various experimental tumors
7. The effect of propranolol on paracetamol metabolism in man
8. Chemical synthesis and growth-promoting activity of all-transretinyl β-D-glucuronide
9. Acetaminophen in chronic liver disease
10. Rapid conjugation in an extremely rapid hydroxylator of debrisoquine: a case report supporting a coregulation of certain phase I and II metabolic reactions
11. Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (part I)
12. Salicyl phenolic glucuronide pharmacokinetics in patients with rheumatoid arthritis
13. Roles of UDP-glucuronosyltransferases in chemical carcinogenesis
14. Differential induction of human liver UDP-glucuronosyltransferase activities by phenobarbital-type inducers
15. Paracetamol as a test drug to determine glucuronide formation in man: effects of inducers and of smoking
16. Morphine-6-glucuronide might mediate the prolonged opioid effect of morphine in acute renal failure
17. The role of therapeutic drug monitoring in children
18. Protein binding of oxazepam and its glucuronide conjugates to human albumin
19. Maternal and neonatal urinary excretion of sulfate and glucuronide ritodrine conjugates
20. Clinical pharmacology of NSAIDs
21. Comparative effects of rifampin and/or probenecid on the pharmacokinetics of temazepam and nitrazepam
22. UDP-glucuronosyltransferases
23. Morphine 6-glucuronide and morphine 3-glucuronide as molecular chameleons with unexpected lipophility
24. Morphine-6-glucuronide has high affinity for the opioid receptor
25. The role of sulphate conjugation in the metabolism and disposition of oral and intravenous paracetamol in man
26. Foreign compounds metabolism by isolated skin cells from the hairless mouse
27. The enantioselective glucuronidation of morphine in rats and humans: evidence for the involvement of more than one UDP-glucuronosyltransferase isozyme
28. The inadequacy of perinatal glucuronidation: immunoblot analysis of the developmental expression of individual UDP-glucuronosyltransferase isozymes in rat and human liver microsomes
29. Inter-subject and ethnic differences in paracetamol metabolism
30. Hepatic extraction of morphine is impaired in cirrhosis
31. A study of conjugation and drug elimination in the human neonate
32. Glucuronidation of E-10-hydroxynortriptyline in human liver, kidney and intestine: organ-specific differences in enantioselectivity
33. Clinical pharmacokinetic considerations in the elderly: an update
34. Alteration of zidovudine pharmacokinetics by probenecid in patients with AIDS or AIDS-related complex
35. Deficiency in bilirubin UDP-glucuronyl transferase as a genetic determinant of acetaminophen toxicity
36. Impaired biliary elimination of β-glucuronidase-resistant ‘glucuronides’ of valproic acid after intravenous administration in the rat: evidence for oxidative metabolism of the resistant isomers
37. Rearrangement of valproate glucuronide in a patient with drug-associated hepatobiliary and renal dysfunction
38. pH-dependent rearrangement of the biosynthetic ester glucuronide of valproic acid to β-glucuronidase-resistant forms
39. Effect of age and gender on disposition of temazepam
40. Glucuronidation of the enantiomers of E-10-hydroxynortriptyline in human and rat liver microsomes
41. Hepatic drug metabolism and aging
42. Drug metabolism in thyroid disease
43. Hepatic drug conjugation/deconjugation systems in hepatosplenic schistosomiasis
44. Effects and metabolic pathway of 4-dimethylaminophenol during kidney perfusion
45. Tocainide kinetics and metabolism: effects of phenobarbital and substrates of glucuronyl transferase
46. Influence of renal failure, rheumatoid arthritis and old age on the pharmacokinetics of diflunisal
47. Properties of acyl glucuronides: implications for studies of the pharmacokinetics and metabolism of acidic drugs
48. The location of drug binding sites in human serum albumin
49. Paracetamol metabolism in chronic liver disease
50. Paracetamol pharmacokinetics in thyroid disease
51. Expression of a human liver cDNA encoding a UDP-glucuronosyl-transferase catalyzing the glucuronidation of hyodeoxycholic acid in cell culture
52. Transplacental transfer and biotransformation studies of valproic acid and its glucuronide(s) in the perfused human placenta
53. Morphine-6-glucuronide is more mu-selective and potent in analgesic tests than morphine
54. Lorazepam kinetics in the elderly
55. Oxazepam kinetics: effects of age and sex
56. Clofibrate disposition in renal failure and acute and chronic liver disease
57. Explanation for potency of repeated oral doses of morphine?
58. Analgesic efficacy and CSF pharmacokinetics of intrathecal morphine-6-glucuronide: comparison with morphine
59. Cloning and substrate specificity of a human phenol UDP-glucuronosyltransferase expressed in COS-7 cells
60. Metabolism of hormones, drugs and other substances by the gut
61. Apparent intramolecular acyl migration of zomepirac glucuronide
62. The metabolism and bioavailability of morphine in patients with severe liver cirrhosis
63. Long lasting respiratory depression induced by morphine-6-glucuronide?
64. Phenobarbital inducible UDP-glucuronosyltransferase is responsible for glucuronidation of 3′-azido-3′deoxythymidine: characterization of the enzyme in human and rat liver microsomes
65. Tumor-targeted cell killing with 8-hydroxyquinolyl-glucuronide
66. The effect of age on glucuronidation and sulphation of paracetamol by human liver fractions
67. Plasma levels and urinary excretion of lormetazepam in patients with liver cirrhosis and in healthy volunteers
68. Acetaminophen absorption and metabolism in celiac disease and Crohn’s disease
69. Drug metabolism in liver disease
70. Is glucuronidation truly preserved in patients with liver disease?
71. Kinetics and biotransformation of lormetazepam
72. Stereoselective binding of the glucuronide conjugates of carprofen enantiomers to human serum albumin
73. Direct determination of diastereomeric carprofen glucuronides in human plasma and urine and preliminary measurements of stereoselective metabolic and renal elimination after oral administration of carprofen in man
74. Cloning of a human microsomal UDP-glucurunosyl transferase cDNA
75. New developments in glucuronidation research: report of a workshop on ‘Glucuronidation, its Role in Health and Disease’
76. Metabolic formation of N- and O-glucuronides of 3-(p-chlorophenyl) thiazolo [3,2-a]benzimidazole-2-acetic acid: rearrangement of the 1-O-acyl glucuronide
77. Morphine-6-glucuronide, an important metabolite
78. Reduction of paracetamol and aspirin metabolism during viral hepatitis
79. Race and therapeutic drug response
80. Effects of uremia and hemodialysis on lormetazepam disposition
81. Age-dependent action of benzodiazepines
82. Pharmacokinetic and pharmacodynamic interaction study with diazepam and metoprolol
83. Arzneistoffwechsel bei Leberkrankheiten
84. Pharmacokinetics and pharmacodynamics in the elderly
85. Effects of aging and liver disease on the disposition of lorazepam
86. Morphine derivatives with diminished opiate receptor potency show enhanced central excitatory activity
87. Simultaneous determination of zomepirac and its major metabolite zomepirac glucuronide in human plasma and urine
88. Odorant signal termination by olfactory UDP glucuronosyl transferase
89. Tricyclic antidepressant and metabolite levels in chronic renal failure
90. Effect of dose on the glucuronidation and sulphation kinetics of diflunisal in man: single dose studies
91. Covalent binding of diflunisal and probenecid to plasma protein in humans: persistence of the adducts in the circulation
92. Oral morphine in cancer pain: influences on morphine and metabolite concentration
93. Reduced clofibric acid clearance in renal dysfunction is due to a futile cycle
94. A renal mechanism for the clofibric acid-probenecid interaction
95. Steroid D-ring glucuronides: characterization of a new class of cholestatic agents in the rat
96. Characterization of paracetamol UDP-glucuronosyltransferase activity in human liver microsomes
97. In vitro evidence for the involvement of at least two forms of human liver UDP-glucuronosyltransferase in morphine 3-glucuronidation
98. Kinetic and inhibitor studies of 4-methylumbelliferone and 1-naphthol glucuronidation in human liver microsomes
99. Comparison of paracetamol metabolism in young adult and elderly males
100. Determinants of acetaminophen metabolism: effect of inducers and inhibitors of drug metabolism on acetaminophen’s metabolic pathways
101. Effect of oral contraceptive steroids on the pharmacokinetics of phenprocoumon
102. Glucuronidation
103. Conversion of the N-O-glucuronide and the N-O-sulfate conjugates of N-hydroxy-phenacetin to reactive intermediates
104. Sources of interindividual variations in acetaminophen and antipyrine metabolism
105. Clinical pharmacokinetics of the salicylates
106. Clinical pharmacokinetics and endocrine disorders: therapeutic implications
107. Temazepam clearance unaltered in cirrhosis
108. Kinetics of diazepam, midazolam, and lorazepam in cigarette smokers
109. Disposition of oxazepam in relation to age, sex, and cigarette smoking
110. Oxazepam disposition in uremic patients
111. Analgesic activity of morphine-6-glucuronide
112. Morphine intoxication in renal failure: the role of morphine-6-glucuronide
113. Morphine-6-glucuronide, a potent MU agonist
114. Differential effects of oral contraceptive steroids on the metabolism of benzodiazepines
115. Normal metabolism of morphine in cirrhosis
116. Pharmacological characterization of morphine-6-β-glucuronide, a very potent morphine metabolite
117. Deconjugation of glucuronides catalysed by UDP glucuronyltransferase
118. Plasma levels of morphine and morphine glucuronides in the treatment of cancer pain: relationship to renal function and route of administration
119. Effects of microsomal enzyme induction on paracetamol metabolism in man
120. Absence of morphine glucuronidation in the human lung
121. Diisopropylfluorophosphate increases clofibric acid clearance: supporting evidence for a futile cycle
122. Reactions of oxaprozin-1-O-acyl glucuronide in solutions of human plasma and albumin
123. Diastereoisomeric glucuronides of oxazepam. Isolation and stereoselective enzyme hydrolysis
124. Effects of posture and sleep on the pharmacokinetics of paracetamol (acetaminophen) and its metabolites
125. Morphine metabolism in cancer patients on increasing oral doses- no evidence for autoinduction or dose-dependence
126. Effect of renal dysfunction on the individual components of the acyl-glucuronide futile cycle
127. Differential effect of cigarette smoking on antipyrine oxidation versus acetaminophen conjugation
128. Effects of age and gender on in vitro properties of human liver microsomal monoxygenases
129. Positive inotropic effects of digitoxin- and digoxin-glucuronide in human isolated ventricular heart muscle preparations
130. Interaction of metoprolol with lorazepam and bromazepam
131. Oxazepam elimination in patients with diabetes mellitus
132. Oxazepam pharmacokinetics in thyroid disease
133. Effect of pentobarbital on the formation of diastereomeric oxazepam glucuronide in man: analysis by high performance liquid chromatography
134. Chlordiazepoxide and oxazepam disposition in cirrhosis
135. Clinical pharmacokinetics of contraceptive steroids: an update
136. Analgesic effect of morphine glucuronides
137. Normal disposition of oxazepam in acute viral hepatitis and cirrhosis
138. Stereoselective disposition and glucuronidation of propranolol in humans
139. The formation of β-glucuronidase resistant glucuronides by the intramolecular rearrangement of glucuronic acid conjugates at mild alkaline pH
140. Species related differences in the stereoselective glucuronidation of oxazepam
141. Hepatoxic effects of estradiol-17-β-D-glucuronide in the rat and monkey
142. Covalent binding of zomepirac glucuronide to proteins: evidence for a Schiff base mechanism
143. Effect of esterase inhibition on the disposition of zomepirac glucuronide and its covalent binding to plasma proteins in the guinea pig
144. Effect of probenecid on the formation and elimination of acyl glucuronides: studies with zomepirac
145. Irreversible binding of zomepirac to plasma protein in vitro and in vivo
146. Morphine-3-glucuronide-a potent antagonist of morphine analgesia
147. Glucuronidation of oxazepam is not spared in patients with hepatic encephalopathy
148. Pharmacokinetics and pharmacodynamics of oxazepam and metabolism of paracetamol in severe hypothyroidism
149. Microsomal acyl glucuronidation: enzyme kinetic studies with labile glucuronides
150. Probenecid-induced changes in the clearance of carprofen enantiomers: a preliminary study
151. Metabolism of low-dose paracetamol in patients with chronic neurological disease
152. Electrophilic reactions of acyl linked glucuronides: formation of clofibrate mercapturate in humans
153. Multiple-dose pharmacokinetics of imipramine and its major active and conjugated metabolites in depressed patients
154. UDP-glucuronosyltransferases a family of detoxifying enzymes
155. Normal pathways for glucuronidation, sulphation and oxidation of paracetamol in Gilbert’s syndrome
156. Acylation of albumin by 1-O-acyl glucuronides
157. Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs
158. Glucuronidation and disposition of drug glucuronides in patients with renal failure
159. Biotransformation and excretion of lorazepam in patients with chronic renal failure
160. Aging and determinants of hepatic drug clearance
161. Human brain sulphotransferase and glucuronyltransferase
162. Structure-activity relationship of the cholestatic activity of dihydrotestosterone glucuronide, allo bile acids and lithocholate
163. Ethynylestradiol-17 β-D-ring glucuronide conjugates are potent cholestatic agents in the rat
164. Metabolic interaction between morphine and naloxone in human liver
165. Human liver morphine UDP-glucuronyl transferase enantioselectivity and inhibition by opioid congeners and oxazepam
166. Presystemic and systemic glucuronidation of propranolol
167. Propranolol glucuronide cumulation during long-term therapy: a proposed storage mechanism for propranolol
168. Interactions between oxaprozin glucuronide and human serum albumin
169. Abnormal glucuronidation of zomepirac in patients with cirrhosis of the liver
170. Intrathecal high dose morphine produces hyperalgesia in the rat
171. Biochemical basis for analgesic activity of morphine-6-glucuronide-I: penetration of morphine-6-glucuronide in the brain of rats
172. Stereoselective glucuronidation as a probe of induced forms of UDP-glucuronyltransferase in rabbits
173. Interindividual and interethnic differences in demethylation and glucuronidation of codeine
174. Glucuronidation of morphine in human kidney microsomes
175. Induction of differentiation of human promyelocytic leukemia cell line HL-60 by retinoyl glucuronide, a biologically active metabolite of vitamin A